You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

~ Buy the CARBOMER 934 Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

Drugs Containing Excipient (Inactive Ingredient) CARBOMER 934


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing CARBOMER 934 excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing CARBOMER 934 excipient

CARBOMER 934 Market Analysis and Financial Projection Experimental

Carbomer 934: Market Dynamics and Financial Trajectory

Introduction to Carbomer 934

Carbomer 934, a type of polyacrylic acid, is a widely used pharmaceutical excipient known for its thickening, stabilizing, and emulsifying properties. It is commonly utilized in various formulations, including personal care products, pharmaceuticals, and homecare items.

Market Size and Growth Projections

The global carbomer market, which includes Carbomer 934, is anticipated to experience significant growth over the coming years.

  • By 2033, the global carbomer market is expected to reach approximately USD 1,657.6 million, growing from USD 866.6 million in 2023 at a CAGR of 6.7%[1].
  • Another projection suggests that the carbomer market could reach USD 1978.3 million by 2030, with a CAGR of 8.9% during the forecast period[2].

Segment Analysis: Carbomer 934

While Carbomer 940 holds a dominant market position, Carbomer 934 also plays a crucial role in the market.

  • Market Share: Although Carbomer 940 captures a significant share (around 44% in 2023), Carbomer 934 is also an important segment, particularly in pharmaceutical and personal care applications[1].
  • Growth Prospects: The demand for Carbomer 934 is expected to rise due to its versatility in various formulations. It is used in bath gels, hair styling gels, lotions, and other personal care products, as well as in pharmaceutical formulations where its thickening and stabilizing properties are valuable[2].

End-Use Applications

Personal Care Products

  • Carbomer 934 is widely used in personal care products such as facial moisturizers, sunscreens, shampoos, and anti-aging treatments. Its ability to form a colloidal, mucilage-like consistency when mixed with water makes it ideal for gel-like formulations[2].

Pharmaceuticals

  • In the pharmaceutical sector, Carbomer 934 is used as an excipient in oral dispersible tablets (ODTs), topical formulations, and other drug delivery systems. Its role in improving the physical stability and rheological properties of these formulations is critical[4].

Regional Analysis

  • The Asia-Pacific region is expected to be a key driver for the carbomer market, including Carbomer 934. This region accounted for 42% of the market share in 2023, valued at USD 363.9 million, due to low labor and manufacturing costs in countries like China and India[1].

Competitive Landscape

  • Key players in the carbomer market include The Lubrizol Corporation, Guangzhou Tinci Materials Technology Co. Ltd., Sumitomo Seika Chemicals Company Ltd., Evonik Industries AG, and SNF s.a.s. These companies are expanding their production capacities and product portfolios to meet the growing demand for carbomers[2].

Recent Developments

  • In October 2023, Lubrizol Corporation announced the expansion of its Carbopol® Aqua SF polymer production capacity in North America to meet the growing demand for high-performance carbomers in personal care and pharmaceutical applications[1].
  • The Korean Ministry of Food and Drug Safety approved BASF’s Luviskol® K30 for use in oral dispersible tablets (ODTs), opening up new opportunities for carbomers in the pharmaceutical market[1].

Market Drivers

  • Increasing Demand for Personal Care and Pharmaceutical Products: The rising consumption of personal care and pharmaceutical products is a significant driver for the carbomer market. Consumer awareness regarding product efficacy and safety further boosts the demand for high-quality formulations that often include Carbomer 934[4].
  • Advancements in Drug Delivery Systems: The need for advanced drug delivery systems and formulations in the pharmaceutical industry is driving the demand for high-quality excipients like Carbomer 934[4].

Market Challenges

  • Regulatory Hurdles: Strict regulations in the pharmaceutical industry can hinder the development and approval of new excipients, including Carbomer 934. High development costs associated with novel excipients are also a significant challenge[3].

Financial Trajectory

  • The financial trajectory of Carbomer 934 is closely tied to the overall carbomer market. With a projected CAGR of 6.7% to 8.9% over the forecast period, the market is expected to see substantial growth.
  • The revenue generated from Carbomer 934 will contribute significantly to the overall market size, which is expected to reach nearly USD 2 billion by 2030[2].

Illustrative Statistics

  • In 2023, the carbomer market was valued at USD 866.6 million, with Carbomer 940 holding a 44% market share. Given the growth projections, Carbomer 934 is expected to contribute a substantial portion to the market's expansion[1].
"Carbomer 934 is used in bath gels, hair styling gels, lotions, and other personal care products, as well as in pharmaceutical formulations where its thickening and stabilizing properties are valuable"[2].

Key Takeaways

  • Market Growth: The carbomer market, including Carbomer 934, is expected to grow significantly, driven by increasing demand in personal care and pharmaceutical sectors.
  • Regional Dominance: The Asia-Pacific region is anticipated to be a major driver for the market.
  • Competitive Landscape: Key players are expanding their production capacities to meet growing demand.
  • Market Drivers: Advancements in drug delivery systems and rising consumer awareness are key drivers.
  • Challenges: Regulatory hurdles and high development costs are significant challenges.

FAQs

What are the primary applications of Carbomer 934?

Carbomer 934 is primarily used in personal care products such as facial moisturizers, sunscreens, and shampoos, as well as in pharmaceutical formulations like oral dispersible tablets and topical treatments.

Which region is expected to drive the growth of the carbomer market?

The Asia-Pacific region is expected to be a key driver for the carbomer market due to low labor and manufacturing costs in countries like China and India.

What are the key drivers for the carbomer market?

The key drivers include increasing demand for personal care and pharmaceutical products, advancements in drug delivery systems, and rising consumer awareness regarding product efficacy and safety.

Who are the major players in the carbomer market?

Major players include The Lubrizol Corporation, Guangzhou Tinci Materials Technology Co. Ltd., Sumitomo Seika Chemicals Company Ltd., Evonik Industries AG, and SNF s.a.s.

What are the challenges faced by the carbomer market?

The market faces challenges such as strict regulations, high development costs associated with novel excipients, and the need for continuous innovation to meet evolving consumer demands.

Sources

  1. Market.us: Carbomer Market Size, Share, Trends | CAGR of 6.7% [https://market.us/report/carbomer-market/]
  2. Prophecy Market Insights: Carbomer Market Size is USD 1978.3 Million by 2030 with CAGR of 8.9% [https://www.prophecymarketinsights.com/PressRelease/Carbomer-Market-1461]
  3. European Pharmaceutical Review: Pharmaceutical excipients market to witness expansion [https://www.europeanpharmaceuticalreview.com/news/189655/pharmaceutical-excipients-market-to-witness-expansion/]
  4. IndustryARC: Carbomer (Polyacrylic Acid) Market Share, Size and Industry Growth [https://www.industryarc.com/Report/17878/carbomer-polyacrylic-acid-market.html]

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.